Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain × Doxycycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Immunoglobulin Light-chain Amyloidosis 3 Pleural Effusion, Malignant 2 Amyloidosis 2 Tuberous Sclerosis 1 Skin Toxicity 1 Ras-wildtype Colorectal Cancer 1 Pancreatic Neoplasms 1 Pain 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphangioleiomyomatosis 1 Intracranial Aneurysm 1 Hemangioma, Cavernous 1 Head and Neck Neoplasms 1 Exanthema 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Arteriovenous Malformations 1 Amyloidosis, Familial 1 Advanced Malignant Neoplasm 1 AA amyloidosis 1

Interventions

Fentanyl 18 Analgesia 14 Acupuncture Therapy 12 Zoledronic Acid 9 Surveys and Questionnaires 9 Oxycodone 9 nabiximols 8 Therapeutics 8 Morphine 8 Acetaminophen 8 Psychiatric Rehabilitation 7 Hydromorphone 7 Lidocaine 6 Ketamine 6 Ibandronic Acid 6 Radiotherapy 5 Bupivacaine 5 Analgesics, Opioid 5 Transcutaneous Electric Nerve Stimulation 4 Therapeutic Touch 4 Ropivacaine 4 Music Therapy 4 Early Intervention, Educational 4 alvimopan 3 Yoga 3 Tapentadol 3 Radiosurgery 3 Radiofrequency Ablation 3 Methadone 3 Dronabinol 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01847976 2019-09-06

OTT12-05

Ottawa Hospital Research Institute

Phase 2 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡